tirzepatide e semaglutide vs Comparative safety and side effects
Description
Since its approval in June 2021, the obesity treatment market has undergone a significant transformation
Find out which expenses count and how to save on treatment.
Greater reductions in BMI, blood pressure, and haemoglobin A1c were observed with tirzepatide
We present a detailed picture showing that epithelial-to-mesenchymal transition, cancer metabolic reprogramming, alterations in important signalling pathways, epigenetic aberrations and the tumour microenvironment are crucial drivers of PTC metastasis
